148 related articles for article (PubMed ID: 6870377)
21. Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.
Introna M; Allavena P; Biondi A; Colombo N; Villa A; Mantovani A
J Natl Cancer Inst; 1983 Jan; 70(1):21-6. PubMed ID: 6337291
[TBL] [Abstract][Full Text] [Related]
22. HNK-1+ (Leu-7) cells and natural killer cell activity in inflamed human gingival tissue.
Komiyama K; Hirsch HZ; Moro I; Umemura S; Mestecky J
J Oral Pathol; 1988 Mar; 17(3):118-23. PubMed ID: 2456375
[TBL] [Abstract][Full Text] [Related]
23. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.
Abo T; Miller CA; Gartland GL; Balch CM
J Exp Med; 1983 Jan; 157(1):273-84. PubMed ID: 6848618
[TBL] [Abstract][Full Text] [Related]
24. A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.
Velardi A; Grossi CE; Cooper MD
J Immunol; 1985 Jan; 134(1):58-64. PubMed ID: 3155472
[TBL] [Abstract][Full Text] [Related]
25. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of monoclonal antibody-defined NK Cells (HNK-1+) in primary immunodeficiency disorders.
Gupta S
Immunol Lett; 1982; 5(6):327-9. PubMed ID: 7166347
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
Abo T; Miller CA; Balch CM; Cooper MD
J Immunol; 1983 Oct; 131(4):1822-6. PubMed ID: 6413578
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of the Leu-7 antigen on human lung tumor cells.
Cole SP; Mirski S; McGarry RC; Cheng R; Campling BG; Roder JC
Cancer Res; 1985 Sep; 45(9):4285-90. PubMed ID: 3928154
[TBL] [Abstract][Full Text] [Related]
29. Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions.
Pizzolo G; Semenzato G; Chilosi M; Morittu L; Ambrosetti A; Warner N; Bofill M; Janossy G
Clin Exp Immunol; 1984 Jul; 57(1):195-206. PubMed ID: 6744669
[TBL] [Abstract][Full Text] [Related]
30. NK activities and HNK-1+ cells in familial polyposis coli.
Chiba M; Masamune O; Yoshida Y; Karouji S
Tohoku J Exp Med; 1987 Jul; 152(3):291-300. PubMed ID: 2821657
[TBL] [Abstract][Full Text] [Related]
31. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
32. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
33. Large granular lymphocyte/natural killer cell proliferative disease: clinical and laboratory heterogeneity.
Bassan R; Introna M; Rambaldi A; Viero P; Chisesi T; Mantovani A; Barbui T
Scand J Haematol; 1986 Aug; 37(2):91-6. PubMed ID: 2945252
[TBL] [Abstract][Full Text] [Related]
34. Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
Hercend T; Griffin JD; Bensussan A; Schmidt RE; Edson MA; Brennan A; Murray C; Daley JF; Schlossman SF; Ritz J
J Clin Invest; 1985 Mar; 75(3):932-43. PubMed ID: 3884668
[TBL] [Abstract][Full Text] [Related]
35. Identification and possible significance of HNK-1+ human lymphocytes, macrophages, and non-neoplastic T-cells in cutaneous lymphoma.
McMillan E; Stoneking LE
Am J Dermatopathol; 1987 Feb; 9(1):2-9. PubMed ID: 3551655
[TBL] [Abstract][Full Text] [Related]
36. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
[TBL] [Abstract][Full Text] [Related]
37. Characterization of HNK-1+ (Leu-7) human lymphocytes. III. Interferon effects on spontaneous cytotoxicity and phenotypic expression of lymphocyte subpopulations delineated by the monoclonal HNK-1 antibody.
Abo T; Balch CM
Cell Immunol; 1982 Nov; 73(2):376-84. PubMed ID: 7159933
[No Abstract] [Full Text] [Related]
38. The distribution of cells expressing a natural killer cell marker (HNK-1) in normal human lymphoid organs and malignant lymphomas.
Mori S; Mohri N; Morita H; Yamaguchi K; Shimamine T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 43(3):253-63. PubMed ID: 6137899
[TBL] [Abstract][Full Text] [Related]
39. [The natural killer blood count in patients with breast, colon and rectal cancers].
Dryzhak VI; Iaremenko AV; Khramtsova NS
Vopr Onkol; 1989; 35(5):585-9. PubMed ID: 2741429
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
